Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Sex Linked Disorders01:43

Sex Linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Association between Gestational Weight Gain and Neonatal Hypoxic and Traumatic Events: Results from a Large Retrospective Cohort.

American journal of perinatology·2026
Same author

Liver regeneration after living donor liver transplantation (LDLT).

Abdominal radiology (New York)·2026
Same author

A Trajectory-Adaptive Model of Early Palliative Care in AML and High-Risk MDS: Real-World Evidence on Core Components and Care Outcomes.

Journal of pain and symptom management·2026
Same author

Chromosome 22q13 terminal deletion size is associated with relevant clinical features in a sample of 63 Italian patients with Phelan-McDermid syndrome.

Journal of neurodevelopmental disorders·2026
Same author

Impaired glucose tolerance in women with BRCA1 versus BRCA2 pathogenic or likely pathogenic variants: Results from a prospective cohort study.

Familial cancer·2026
Same author

Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer's disease.

The Cochrane database of systematic reviews·2026

関連する実験動画

Updated: Jul 10, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

再発性寛解性多発性硬化症におけるインターフェロン:体系的なレビュー

Graziella Filippini1, Luca Munari, Barbara Incorvaia

  • 1Unità di Neuroepidemiologia, Istituto Nazionale Neurologico C Besta, Milan, Italy. gfilippini@istituto-besta.it

Lancet (London, England)
|February 25, 2003
PubMed
まとめ
この要約は機械生成です。

リコンビナントインターフェロンは,再発性寛解性多発性硬化症の悪化を最初の1年でわずかに軽減する可能性があります. これらのMS治療の長期的な効果と副作用については,新しい臨床試験でさらなる調査が必要です.

さらに関連する動画

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

関連する実験動画

Last Updated: Jul 10, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

科学分野:

  • 神経学 神経学とは
  • 免疫学 免疫学とは
  • 薬理学 薬理学とは

背景:

  • 再結合インターフェロンは,再発性寛解性多発性硬化症 (RRMS) の治療に承認されています.
  • RRMS管理におけるその有効性,利益,副作用,コストに関する議論が続いている.
  • エビデンス・シンセシスは,RRMSの治療において,情報に基づいた臨床的意思決定に不可欠です.

研究 の 目的:

  • RRMSの治療における再結合インターフェロンの有効性を評価する.
  • 併用インターフェロンが,プラセボと比較して,臨床的悪化と疾患進行を軽減するかどうかを判断する.
  • RRMS患者のステロイド使用と入院に対する再結合インターフェロンの影響を評価する.

主な方法:

  • コクラン・コラボレーションの方法論を用いたランダム化,プラセボ対照試験の系統的レビュー (1993-2002)
  • 再結合インターフェロンで治療されたRRMS患者1215人を含む.
  • 悪化,疾患進行,ステロイド使用,入院,MRIの結果に関するデータを分析した.

主要な成果:

  • インターフェロンは,第1年 (RR 0.73) で悪化を減らす傾向を示しました.
  • 2年後の結果は,中退と感受性分析のため,決定的ではありませんでした.
  • 一般的な副作用は,患者の生活の質に悪影響を及ぼし,ステロイド使用,入院,MRIの結果に関するデータが不十分である.

結論:

  • リコンビナントインターフェロンは,RRMS治療の最初の1年間,悪化をわずかに軽減します.
  • これらの多発性硬化症の治療法の長期的な臨床効果は依然として不確実である.
  • RRMSにおける再結合インターフェロンの長期的な有効性および安全性プロフィールを完全に評価するために,さらなる試験が必要である.